$CBRS

Cerebras Director's Entities Receive 44,507 Shares

Cerebras Systems Inc. (CBRS) director's entities received 44,507 shares on September 21, 2026, according to an SEC Form 4 filing. The shares were acquired at $0.00, with the director indirectly beneficially owning 275,854 shares post-transaction.

Original reporting
Published Sep 23, 2026, 9:11 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 23, 2026, 9:45 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$CBRS
Neutral
medium confidence
Mentioned
$CBRS
Relevance
5/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$CBRSNeutralLow
01

Why it matters

The filing provides fresh, primary data on insider activity, which may be used by traders to gauge management confidence.

02

Market read

Insider purchases are closely monitored; while the size is modest, the filing is a primary source of new information.

03

What to watch

No disclosed price or transaction value; the financial impact may be negligible.

Relevance 5/10Novelty 6/10Timing: Form 4 filed 09/21/2026 (same-day filing)

Background

SEC Form 4 filings disclose changes in beneficial ownership by insiders. This filing reports a director's acquisition of Cerebras common stock.

Company-level read

Ticker impact

$CBRSNeutralMedium confidence
Context

Director purchased 44,507 shares of Cerebras Systems Inc. as disclosed in a Form 4 filing on 09/21/2026.

Expected impact

Limited upside pressure; price may edge higher if market views the purchase positively.

Evidence & confidence

A director buying ~44k shares is modest in dollar terms, but insider activity is closely watched by traders.

Market effects

Minimal; reflects only company-specific insider activity.

None

None

Counterpoint

The purchase could be a routine portfolio rebalancing, not a strong endorsement.

Key entities

  • Cerebras Systems Inc.

    AI hardware company listed on NASDAQ under ticker CBRS.

  • Unnamed Director

    Director of Cerebras who acquired 44,507 shares.

Related articles

$CBRSMed

Cerebras (CBRS) Plants A 165 MW Flag In Finland While Still Losing Money

Cerebras Systems (CBRS) announced a new AI data center in Finland with partner Compute Nordic Finland, set to reach 165 MW capacity. The project is backed by contracts and will be built in stages. Cerebras reported a 281% increase in cloud revenue for the quarter, but still operates at a loss. The company raised its full-year outlook but expects lower margins in the third quarter. Hedge fund ownership increased significantly, while short interest remains high.

$CBRSHighAI 8/10

Cerebras Drops 19% in 3 Months: Buy, Sell or Hold the Stock?

Cerebras Systems (CBRS) shares fell 19% in 3 months due to profitability concerns, margin pressure, and competition. Q3 2026 revenue guidance is $214-$216M, with margins expected to decline. The company faces customer concentration risks and competition from NVIDIA, AMD, and Intel. Despite strong RPO and expansion plans, near-term challenges persist. Analysts see a 56.93% upside potential.

$CBRSMedAI 8/10

Cerebras Has a $25.4 Billion Backlog, and One OpenAI Agreement Is Behind Much of It

Cerebras Systems reported Q2 adjusted revenue of $209.9M, up 103% YoY, with a $25.4B backlog driven by an OpenAI agreement. The company raised its full-year outlook to $880M-$890M. OpenAI's deal accounts for most of the backlog, with revenue recognition expected over several years. Cerebras' stock is down 44% from its 52-week high, trading at a market cap of ~$51B.

$CBRSHighAI 8/10

CBRS Stock Surges 68% On Nasdaq Debut: Cathie Wood's ARK Buys Shares While Trimming TSMC, AMD

Cerebras Systems (CBRS) shares surged 68% on their Nasdaq debut, closing at $311.07, with a market cap of $95B. ARK ETFs bought 105,616 shares, while trimming stakes in TSMC and AMD. The IPO raised $5.6B, with strong demand highlighting investor interest in AI hardware. CBRS reported $510M in 2023 sales, up from $290.3M in 2024, and partners with OpenAI, Meta, AWS, and IBM.

$CBRSMed

CBRS Stock Slides As Cerebras Ramps AI Capacity And Growth

Cerebras Systems Inc. (CBRS) stock rose 10.73% on September 4, 2026, driven by investor optimism around AI chip adoption. The company reported Q2 2026 revenue of $510M and a loss of $451M, with a high price-to-sales multiple of 117x. Morgan Stanley reiterated its overweight rating, citing strong AI demand and partnerships. CBRS faces execution risks due to high spending on AI capacity expansion.